<SEC-DOCUMENT>0001564590-21-022243.txt : 20210430
<SEC-HEADER>0001564590-21-022243.hdr.sgml : 20210430
<ACCEPTANCE-DATETIME>20210430085859
ACCESSION NUMBER:		0001564590-21-022243
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20210430
FILED AS OF DATE:		20210430
DATE AS OF CHANGE:		20210430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioNTech SE
		CENTRAL INDEX KEY:			0001776985
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			2M
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39081
		FILM NUMBER:		21874039

	BUSINESS ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
		BUSINESS PHONE:		0049613190847081

	MAIL ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>bntx-6k_20210430.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
bntx-6k_20210430.DOCX.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:20pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION<font style="font-weight:normal;"> </font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549<font style="font-weight:normal;color:#000000;"> </font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:20pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gl04fjvuohx1000001.jpg" title="" alt="" style="width:168px;height:0px;"><br /><font style="font-weight:bold;">FORM 6-K</font> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gl04fjvuohx1000002.jpg" title="" alt="" style="width:168px;height:0px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a&#8209;16 OR 15d&#8209;16<font style="font-weight:normal;color:#000000;"> </font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNDER THE SECURITIES EXCHANGE ACT OF 1934<font style="font-weight:normal;color:#000000;"> </font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FOR THE MONTH OF APRIL 2021<font style="font-weight:normal;color:#000000;"> </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gl04fjvuohx1000003.jpg" title="" alt="" style="width:168px;height:0px;"></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">COMMISSION FILE NUMBER 001-39081 </p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">BioNTech SE<br /><font style="color:#333333;font-size:10pt;font-weight:normal;">(Translation of registrant&#8217;s name into English)</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">An der Goldgrube 12</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">D-55131 Mainz</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Germany</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">+49 6131-9084-0<br /><font style="color:#333333;font-size:10pt;font-weight:normal;">(Address of principal executive offices)</font><font style="font-weight:normal;color:#000000;"> </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gl04fjvuohx1000004.jpg" title="" alt="" style="width:168px;height:0px;"></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20&#8209;F or Form 40&#8209;F:<font style="color:#000000;"> </font>Form 20&#8209;F <font style="font-family:Segoe UI Symbol;">&#9746;</font> Form 40&#8209;F <font style="font-family:Segoe UI Symbol;">&#9744;</font><font style="color:#000000;"> </font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is submitting the Form 6&#8209;K in paper as permitted by Regulation S&#8209;T Rule 101(b)(1):<font style="color:#000000;"> </font><font style="font-family:Segoe UI Symbol;">&#9744;</font> </p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is submitting the Form 6&#8209;K in paper as permitted by Regulation S&#8209;T Rule 101(b)(7)<font style="color:#000000;">: </font><font style="font-family:Segoe UI Symbol;">&#9744;</font> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;">DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 30, 2021, BioNTech SE (the &#8220;Company&#8221;) and Pfizer Inc. announced that they have submitted a variation to the Conditional Marketing Authorization in the European Union to the European Medicines Agency for the Pfizer-BioNTech vaccine COMIRNATY&#174; (BNT162b2) to request an extension of the indication for use in adolescents 12 to 15 years of age. The press release is attached hereto as Exhibit 99.1.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:14pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;">SIGNATURE</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.14%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<font style="color:#000000;"> </font></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:50.63%;"></td>
<td style="width:4.63%;"></td>
<td style="width:44.73%;"></td>
</tr>
<tr style="height:1pt;">
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">BioNTech SE</p></td>
</tr>
<tr style="height:1pt;">
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-Top:0pt; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Dr. Sierk Poetting</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt; border-top:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Dr. Sierk Poetting</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:&nbsp;&nbsp; Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: April 30, 2021 </p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;">EXHIBIT INDEX </font></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:10.98%;"></td>
<td style="width:89.02%;"></td>
</tr>
<tr style="height:1pt;">
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit</font></p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Description of Exhibit</font></p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <a href="bntx-ex991_6.htm"><font style="font-family:Times New Roman;text-decoration:underline;">Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY&#174; in the EU to Adolescents</font></a><font style="font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
</table></div>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bntx-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
bntx-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:49.94%;"></td>
<td style="width:49.94%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gdtodyoqoyfd000001.jpg" title="" alt="" style="width:209px;height:86px;"></p></td>
<td valign="middle" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gdtodyoqoyfd000002.jpg" title="" alt="" style="width:240px;height:26px;"></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup><sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup>in the EU<sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup>to Adolescents</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NEW YORK and MAINZ, GERMANY, April 30, 2021 (GLOBE NEWSWIRE)<font style="font-weight:normal;"> &#8212; </font><font style="text-decoration:underline;font-weight:normal;">Pfizer Inc.</font><font style="font-weight:normal;"> (NYSE: PFE) and </font><font style="text-decoration:underline;font-weight:normal;">BioNTech SE</font><font style="font-weight:normal;"> (Nasdaq: BNTX) today announced they have submitted a variation to the Conditional Marketing Authorization (CMA) in the European Union (EU) to the European Medicines Agency (EMA) for the Pfizer-BioNTech vaccine COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> (BNT162b2) to request an extension of the indication for use in </font><font style="Background-color:#FFFFFF;color:#000000;font-weight:normal;">adolescents 12 to 15 years of age. If EMA approves the variation, the amended CMA will be valid in all 27 member states of the EU. The companies</font><font style="font-weight:normal;"> have already submitted a similar request to the </font><font style="Background-color:#FFFFFF;color:#000000;font-weight:normal;">U.S. Food and Drug Administration (FDA) for the </font><font style="font-weight:normal;">Emergency Use Authorization (EUA) and plan to request additional amendments with other regulatory authorities worldwide</font><font style="Background-color:#FFFFFF;color:#000000;font-weight:normal;">.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">This submission is based on data from a pivotal Phase 3 clinical trial, which enrolled 2,260 participants aged 12 to 15 years. Topline results from this trial, </font><font style="Background-color:#FFFFFF;text-decoration:underline;">announced</font><font style="Background-color:#FFFFFF;"> on March 31, 2021, showed a vaccine efficacy of 100% in participants with or without prior SARS-CoV-2 infection and robust antibody responses. In the trial, the vaccine also was generally well tolerated. Participants will continue to be monitored for long-term protection and safety for an additional two years after their second dose.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Pfizer-BioNTech COVID-19 vaccine<font style="color:#000000;">, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the European Union, and the holder of emergency use authorizations or equivalent in the United States (jointly with Pfizer), United Kingdom, Canada and other countries in advance of a planned application for full marketing authorizations in these countries.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AUTHORIZED USE IN THE EU: </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> &#9660;<font style="font-weight:normal;"> (the Pfizer-BioNTech COVID-19 vaccine) has been granted conditional marketing authorisation by the by the European Commission to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. The European Medicines Agency&#8217;s (EMA&#8217;s) human medicines committee (CHMP) has completed its rigorous evaluation of COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>, concluding by consensus that sufficiently robust data on the quality, safety and efficacy of the vaccine are now available.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">IMPORTANT SAFETY INFORMATION: </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">Events of anaphylaxis have been reported. Appropriate medical treatment and supervision should always be readily available in case of an anaphylactic reaction following the administration of the vaccine.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">The efficacy, safety and immunogenicity of the vaccine has not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> may be lower in immunosuppressed individuals.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">As with any vaccine, vaccination with COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> may not protect all vaccine recipients. Individuals may not be fully protected until 7 days after their second dose of vaccine.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">In clinical studies, adverse reactions in participants 16 years of age and older were injection site pain (&gt; 80%), fatigue (&gt; 60%), headache (&gt; 50%), myalgia and chills (&gt; 30%), arthralgia (&gt; 20%), pyrexia and injection site swelling (&gt; 10%) and were usually mild or moderate in intensity and resolved within a few days after vaccination. A slightly lower frequency of reactogenicity events was associated with greater age.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">There is limited experience with use of COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> in pregnant women. Administration of COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> in pregnancy should only be considered when the potential benefits outweigh any potential risks for the mother and fetus.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">It is unknown whether COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> is excreted in human milk.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">Interactions with other medicinal products or concomitant administration of COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> with other vaccines has not been studied.</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.97%;white-space:nowrap">
<p style="text-align:justify;margin-top:0pt;margin-bottom:8pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:0pt;margin-bottom:8pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="text-decoration:none;Background-color:#auto;font-size:10pt;font-family:'Times New Roman';"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">For complete information on the safety of COMIRNATY</font><font style="font-size:10pt;font-family:Arial;color:#000000;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup></font><font style="font-size:10pt;font-family:Arial;color:#000000;"> always make reference to the approved Summary of Product Characteristics and Package Leaflet available in all the languages of the European Union on the EMA website. </font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The black equilateral triangle denotes that additional monitoring is required to capture any adverse reactions. This will allow quick identification of new safety information. Individuals can help by reporting any side effects they may get. Side effects can be reported to <font style="text-decoration:underline;">EudraVigilance</font> or directly to BioNTech using email <font style="text-decoration:underline;">medinfo@biontech.de</font>, telephone&#160;+49 6131 9084 0, or via the website&#160;<font style="text-decoration:underline;">www.biontech.de</font>. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About Pfizer: Breakthroughs That Change Patients&#8217; Lives</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at <font style="text-decoration:underline;color:#0563C1;">www.Pfizer.com</font>. In addition, to learn more, please visit us on <font style="text-decoration:underline;color:#0563C1;">www.Pfizer.com</font> and follow us on Twitter at <font style="text-decoration:underline;">@Pfizer</font> and <font style="text-decoration:underline;">@Pfizer News</font>, <font style="text-decoration:underline;">LinkedIn</font>, <font style="text-decoration:underline;">YouTube</font> and like us on Facebook at <font style="text-decoration:underline;">Facebook.com/Pfizer</font>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk68699118"></a><a name="_Hlk54352787"></a><a name="_Hlk54352787"></a>Pfizer Disclosure Notice </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information contained in this release is as of April 30, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This release contains forward-looking information about Pfizer&#8217;s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162 mRNA vaccine program and COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup><font style="font-weight:bold;">, </font>the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) (including qualitative assessments of available data, potential benefits, expectations for clinical trials, the potential of BNT162b2 for adolescents 12 to 15 years of age, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply) involving substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with preclinical and clinical data (including the topline data outlined in this release), including the possibility of unfavorable new preclinical, clinical or safety data and further analyses of existing preclinical, clinical or safety data (including the topline data outlined in this release); the ability to produce comparable clinical or other results, including the rate of vaccine effectiveness and safety and tolerability profile observed to date, in additional analyses of the Phase 3 trial and additional studies or in larger, more diverse populations following commercialization; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the risk that more widespread use of the vaccine will lead to new information about efficacy, safety, or other developments, including the risk of additional adverse reactions, some of which may be serious; the risk that preclinical and clinical trial data (including the topline data outlined in this release) are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when additional data from the BNT162 mRNA vaccine program (including the topline data outlined in this release) will be published in scientific journal publications and, if so, when and with what modifications and interpretations; whether regulatory authorities will be satisfied with the design of and results from these and any future preclinical and clinical studies; whether and when a Biologics License Application for BNT162b2 may be filed in the U.S. and whether and when other biologics license and/or emergency use authorization applications or amendments to any such applications may be filed in particular jurisdictions for BNT162b2 or any other potential vaccines that may arise from the BNT162 program, </p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and if obtained, whether or when such emergency use authorization or licenses will expire or terminate; whether and when any applications that may be pending or filed for BNT162b2 (including a potential Biologics License Application in the U.S. or any requested amendments to the emergency use or conditional marketing authorizations) or other vaccines that may result from the BNT162 program may be approved by particular regulatory authorities, which will depend on myriad factors, including making a determination as to whether the vaccine&#8217;s benefits outweigh its known risks and determination of the vaccine&#8217;s efficacy and, if approved, whether it will be commercially successful; decisions by regulatory authorities impacting labeling or marketing, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of a vaccine, including development of products or therapies by other companies; disruptions in the relationships between us and our collaboration partners, clinical trial sites or third-party suppliers; the risk that demand for any products may be reduced or no longer exist; risks related to the availability of raw materials to manufacture a vaccine; challenges related to our vaccine&#8217;s ultra-low temperature formulation, two-dose schedule and attendant storage, distribution and administration requirements, including risks related to storage and handling after delivery by Pfizer; the risk that we may not be able to successfully develop other vaccine formulations; the risk that we may not be able to create or scale up manufacturing capacity on a timely basis or maintain access to logistics or supply channels commensurate with global demand for our vaccine, which would negatively impact our ability to supply the estimated numbers of doses of our vaccine within the projected time periods as previously indicated; whether and when additional supply agreements will be reached; uncertainties regarding the ability to obtain recommendations from vaccine advisory or technical committees and other public health authorities and uncertainties regarding the commercial impact of any such recommendations; challenges related to public vaccine confidence or awareness; uncertainties regarding the impact of COVID-19 on Pfizer&#8217;s business, operations and financial results; and competitive developments.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A further description of risks and uncertainties can be found in Pfizer&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned &#8220;Risk Factors&#8221; and &#8220;Forward-Looking Information and Factors That May Affect Future Results&#8221;, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at&#160;<font style="text-decoration:underline;">www.sec.gov&#160;</font>and&#160;<font style="text-decoration:underline;">www.pfizer.com</font>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About BioNTech </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit <font style="text-decoration:underline;">www.BioNTech.de</font>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br />BioNTech Forward-looking Statements</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This press release contains &#8220;forward-looking statements&#8221; of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, statements concerning: BioNTech&#8217;s efforts to combat COVID-19; the collaboration between BioNTech and Pfizer to develop a potential COVID-19 vaccine; our expectations regarding the potential characteristics of BNT162b2 (COMIRNATY<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>) in our Phase 2/3 trial and/or in commercial use based on data observations to date; the expected timepoint for additional readouts on efficacy data of BNT162b2 in our Phase 2/3 trial; the nature of the clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the timing for submission of data for, or receipt of, any marketing approval or Emergency Use Authorization; our contemplated shipping and storage plan, including our estimated product shelf-life at various temperatures; and the ability of BioNTech to supply the quantities of BNT162 to support clinical development and market demand, including our production estimates for 2021. Any forward-looking statements in this press release are based on BioNTech&#8217;s </p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">current expectations and beliefs of future events. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond BioNTech&#8217;s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. You should review the risks and uncertainties described under the heading &#8220;Risk Factors&#8221; in BioNTech&#8217;s Annual Report on Form 20-F for the Year Ended December 31, 2020, filed with the SEC on March 30, 2021, which is available on the SEC&#8217;s website at . All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Pfizer Contacts: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Media Relations </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Andy Widger</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+44 (0)1737 330909 </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">eupress@pfizer.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chuck Triano</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+1 (212) 733-3901</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Charles.E.Triano@Pfizer.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">BioNTech Contacts:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Media Relations</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jasmina Alatovic</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+49 (0)6131 9084 1513</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Media@biontech.de </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sylke Maas, Ph.D.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+49 (0)6131 9084 1074</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Investors@biontech.de</font> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gdtodyoqoyfd000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gdtodyoqoyfd000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $M"JD# 2(  A$! Q$!_\0
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MT:/M$W_/:3_OHU'10%V2?:)O^>TG_?1H^T3?\]I/^^C4=% 79)]HF_Y[2?\
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MYC?.W4]Z]$KSF3_6-]37S^>MI4_G^A40\Q_[[?G1YC_WV_.FT5\[=E#O,?\
MOM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_
M.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\
MOM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_
M.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\
MOM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_
M.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\
MOM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_
M.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\ OM^='F/_ 'V_.FT478#O,?\
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MT:/M$W_/:3_OHU'10%V2?:)O^>TG_?1H^T3?\]I/^^C4=% 79)]HF_Y[2?\
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MY5E."#3N==+&5(:/5'T-17FGAWXA2P;+;6<RQ]!<J/F7_>'?Z]?K7H\$\5S
MD\$BR1.,JZG((IGJTJT*JO$DHHHH-0HHHH **** "BBB@ HHHH **** .2\4
M?\A./_KB/YM6)6WXH_Y"<?\ UQ'\VK$KXG,?]ZGZFBV"BBBN( HHHH ****
M)[6[FLIUFA;:PZCL1Z&NSTW5(=1ARORRJ/G0]OI[5PM20S26\JRQ.4=3D$5Z
M&!Q\\+*V\>W^0FKGHE%9FDZQ'J";'PEP!RO][W%:=?7T:T*T%.#NB HHHK0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KSF3_6-]37HU><R?ZQOJ:^?S[:G\_P!"HC:***^<*"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\9\=?\
M(Y7_ /VS_P#1:U[-7C/CK_D<K_\ [9_^BUI,X<P_A+U_S.=HHHI'D!1110 5
M[-7C->S4SMP?VOD>.W'_ !\R_P"^?YU'76R_#[7GF=A'!@L2/WHIO_"O-?\
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M_D&V'_79OY4,Y\7_  9'F5%%%2>$%%%% !7KOP\_Y%2/_KL_\Z\BKUWX>?\
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M<UC-Y4P ;&[@YXJO7-*,H2Y9*S0!1114@%%%% !16JGAZ_=%8+'AAD?/3O\
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M^%>:_P#\\[?_ +^B@/J]7^5G*45U?_"O-?\ ^>=O_P!_11_PKS7_ /GG;_\
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M** "O9J\9KV:F=N#^U\CHJ***9[ 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(RJZE7
M4,I&"",@TM% '(:[X!T_45>6P"V=T>0%'[MOJ.WX?D:\PU#3[K2[Q[2\B,<R
M=0>A'J#W%>_5A>*/#L.OZ:R!56[C!,$GH?[I]C_]>E8X<1A(S7-#1GBE%.DC
M>*1HY%*NA*LIZ@CJ*;2/("BBB@ IT;M%(LB,5="&4CL13:* /?\ 3KM;_3;:
M[7I-$KX],CI5FN9\!7)N/"5LI.3"SQG\\C]"*Z:J/HJ<N:"EW"BBB@L****
M"N$^)_\ R#;#_KLW\J[NN$^)_P#R#;#_ *[-_*AG/B_X,CS*BBBI/""BBB@
MKUWX>?\ (J1_]=G_ )UY%7KOP\_Y%2/_ *[/_.FCMP'\7Y'5T444SV HHHH
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MV?$W_(5'_7(?S-8U?$8__>I^IHM@HHHKC **** /0[?_ (]HO]P?RJ6HK?\
MX]HO]P?RJ6OT&'PHS"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBJ&M:K#HNE37TW.P81?[S'H*!-J*NSF_'?B<Z9;?V;9OB[F7]X
MP/,:?XG_ #VKRJI[R[FO[R6[N'WS2L68_P">U04CP:]9U9WZ!1112,0HHHH
M**** "BM?1O#>IZZ_P#HD&(<X::3A!^/?\*]#TCX?:78!9+W-[,.3OX0?\![
M_C3-Z6&J5=4M#S&QTJ_U.3996DLY[E%X'U/05U-A\-=2G :]N8;5?[H_>-^G
M'ZUZA%%'#&L<4:QHHP%08 _"GT6/0A@(+XG<Y"S^'.BP &X:XNF[AGVK^2\_
MK6Y;>'=&L\>1IEJI'1C&&/YGFM.BF=,:-..R$5510JJ%4= !BEHHH-0HHHH
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MT3'YT/?Z>]=G:7<-[ LT+;E/4=P?0U]=@<?#%1MM+M_D0U8GHHHKT!!1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O&?'7_(Y7__ &S_ /1:U[-7C/CK_D<K_P#[9_\
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M]:]6J"RLX=/LH;2W3;#$H51_GO4]4>]0HJE"W4****#8**** "BBB@ HHHH
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MS(:L7Z***]404444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ***9[ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9O<5J5YPCLCAT8JRG((/(KK='UQ;L+;W)"S] W9__KU]/EV:*K:E6^+H^_\
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MZ7/49Z#\!C\<UT-%%4?10@H145T"BBB@H**** "BBB@ HHHH **** "BBB@
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M^T0_\]H_^^A0%T245']HA_Y[1_\ ?0H^T0_\]H_^^A0%T244=1D44#"BBB@
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M'_GM'_WT* NB2BH_M$/_ #VC_P"^A1]HA_Y[1_\ ?0H"Z)**C^T0_P#/:/\
M[Z%'VB'_ )[1_P#?0H"Z)**C^T0_\]H_^^A1]HA_Y[1_]]"@+HDHJ/[1#_SV
MC_[Z%'VB'_GM'_WT* NB2O&?'7_(Y7__ &S_ /1:U[,"",@Y!KQGQU_R.5__
M -L__1:TF<68?PEZ_P"9SM%%%(\@**** "O9J\9KV:F=N#^U\CQVX_X^9?\
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MX0T]<8RC-^;$_P!:WJH^@H*U**\@HHHH-0HHHH **** "BBB@ HHHH ****
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MM(8^?D15YZ\"FCT<O7O29+1113/4"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** .4^(?_(J2?\ 79/YUY%7KOQ#_P"14D_Z[)_.O(J3
M/&Q_\7Y!1112.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KV:O&:]FIG;@_M?(\=N/^/F7_?/\ZCJ2X_X^9?]\_SJ.D<3W"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .@TKPE=:M%')%?6$8D&0KSY<?\  1GFNPTW
MX:V,!#ZA<R73#^!!L7\>Y_,5Y?6OIOB?6-*(%M>R>6/^64AWI^1Z?A3.FC4H
MQ?OQ_KT/:K2RM;" 06D$<,8_A1<"IZXG1/B+9WC+#J<8M)3P) <QD_S7]1[U
MVB.LB*Z,&1AE64Y!%,]BE4A->XQU%%%!H%%%% !1110 4444 %<)\3_^0;8?
M]=F_E7=UPGQ/_P"0;8?]=F_E0SGQ?\&1YE1114GA!1110 5Z[\//^14C_P"N
MS_SKR*O7?AY_R*D?_79_YTT=N _B_(ZNBBBF>P%%%% !1110!Y5\3/\ D9+?
M_KT7_P!#>N,KL_B9_P C);_]>B_^AO7&4CP<3_&D%%%%(P"BBB@#W'PJNSPM
MIHSG]PI_/FM>L?PHQ;PKII/_ #Q _*MBJ/HJ7P+T"BBB@L**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KS'XG*!JMBW<P$?DW_UZ].KS'XG,#JMBG<0$_FW_P!:AG)C?X+.%HHHJ3Q0
MHHHH *]J\%_\BAI_^XW_ *$:\5KVKP7_ ,BAI_\ N-_Z$::.[+_XC]#>HHHI
MGKA1110 4444 <EXH_Y"<?\ UQ'\VK$K;\4?\A./_KB/YM6)7Q.8_P"]3]31
M;!1117$ 4444 >@V7_'C;_\ 7)?Y5/4%E_QXV_\ UR7^53U^@4_@7H9A1115
M@%%%% !1110 4444 %5KVQAOX#%,O^ZPZJ:LT5,X1G%QDKI@<%?Z?-I\_ERC
M*G[KCHU5*]"N;6&[@:&9 RG\Q[BN-U/2I=.EY^>%C\K_ -#[U\IF&6RP[YX:
MQ_(M.YGT445Y(PHHHH **** +NFZG-ITVY/FC;[\9/!_^O7:6EW#>P":!LJ>
MH[@^AKSZK-E?36$XEA;_ 'E/1A7JY?F4L.^2>L?R]!-7._HJI8:A#J$'F1'#
M#[R'JM6Z^LA.-2*E%W3("BBBJ **** "BBB@ HHHH *\YD_UC?4UZ-7G,G^L
M;ZFOG\^VI_/]"HC:***^<*"BBB@#0T3_ )#-M_O'^1KN*X?1/^0S;?[Q_D:[
MBOJ<C_@2]?T1,@HHHKVB0HHHH **** "BBB@ HHHH **** .0\3?\A4?]<A_
M,UC5L^)O^0J/^N0_F:QJ^(Q_^]3]31;!1117& 4444 >AV__ ![1?[@_E4M1
M6_\ Q[1?[@_E4M?H,/A1F%%%%4 4444 %%%% !1110 4444 %<A\1_\ D6%_
MZ^4_DU=?7(?$?_D6%_Z^4_DU!CB?X4O0\FHHHJ3P HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#W_3_P#D&VO_ %Q3^0JS5;3_ /D&
MVO\ UQ3^0JS5'TD=D%%%% PHHHH *\2\7,6\6:B2<_O<?D!7MM>)>+U*^+-1
M!_YZY_,"DS@S#^&O4Q****1Y(4444 %?1%?.]?1%-'I9=]KY?J%%%%,],***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y3XA_\ (J2?
M]=D_G7D5>N_$/_D5)/\ KLG\Z\BI,\;'_P 7Y!1112.,**** "BBB@ HHHH
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M>?\ (J1_]=G_ )TT=N _B_(ZNBBBF>P%%%% !1110!Y?\3@?[:LVQP;?&?\
M@1KAZ[_XH1XN]-DY^9'7\B/\:X"DSPL6K5I!1112.<**** /:?!,GF^$-/.<
MX5EZ^CL*WZY'X<S^;X8,>>8IW7'UP?ZUUU4?04'>E%^04444&H4444 %%%%
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M ,_-A_W\?_XBC_A6>L_\_-A_W\?_ .(H#ZM6_E.,HKL_^%9ZS_S\V'_?Q_\
MXBC_ (5GK/\ S\V'_?Q__B* ^K5OY3C**[/_ (5GK/\ S\V'_?Q__B*/^%9Z
MS_S\V'_?Q_\ XB@/JU;^4XRBNS_X5GK/_/S8?]_'_P#B*/\ A6>L_P#/S8?]
M_'_^(H#ZM6_E.,HKL_\ A6>L_P#/S8?]_'_^(H_X5GK/_/S8?]_'_P#B* ^K
M5OY3C**[/_A6>L_\_-A_W\?_ .(H_P"%9ZS_ ,_-A_W\?_XB@/JU;^4XRBNS
M_P"%9ZS_ ,_-A_W\?_XBC_A6>L_\_-A_W\?_ .(H#ZM6_E.,HKL_^%9ZS_S\
MV'_?Q_\ XBC_ (5GK/\ S\V'_?Q__B* ^K5OY3C**[/_ (5GK/\ S\V'_?Q_
M_B*/^%9ZS_S\V'_?Q_\ XB@/JU;^4XRBNS_X5GK/_/S8?]_'_P#B*/\ A6>L
M_P#/S8?]_'_^(H#ZM6_E.,HKL_\ A6>L_P#/S8?]_'_^(H_X5GK/_/S8?]_'
M_P#B* ^K5OY3C**[/_A6>L_\_-A_W\?_ .(H_P"%9ZS_ ,_-A_W\?_XB@/JU
M;^4XRBNS_P"%9ZS_ ,_-A_W\?_XBC_A6>L_\_-A_W\?_ .(H#ZM6_E/3-/\
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M7J_RLY"BNO\ ^%<:Y_?M/^_I_P */^%<:Y_?M/\ OZ?\* ^KU?Y6<A177_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P!<1_-JQ*^)S'_>I^IHM@HHHKB **** /0;+_CQM_\ KDO\JGJ"R_X\;?\
MZY+_ "J>OT"G\"]#,****L HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MR-7T5+X&:'"7 _)_K[^]<A)&\4C1R*5=3@@CD5Z-6;JND1:C'N&$G4?*_K['
MVKQ<QRM5KU*6DNW?_@E)G$T5+<6\MK,T,R%77J#45?+M.+L]R@HHHI %%%%
M!6_HVNF';;7;$Q=$D/\ #]?:L"BM\/B*F'GSP8-7/1P0P!!!!&01WI:X_2-;
M>R(AG)>W/3U3Z>WM771R)+&KQL&1AD$=#7V&#QM/%0O'?JB&K#J***[!!7G,
MG^L;ZFO1J\YD_P!8WU-?/Y]M3^?Z%1&T445\X4%%%% &AHG_ "&;;_>/\C7<
M5P^B?\AFV_WC_(UW%?4Y'_ EZ_HB9!1117M$A1110 4444 %%%% !1110 44
M44 <AXF_Y"H_ZY#^9K&K9\3?\A4?]<A_,UC5\1C_ />I^IHM@HHHKC ****
M/0[?_CVB_P!P?RJ6HK?_ (]HO]P?RJ6OT&'PHS"BBBJ **** "BBB@ HHHH
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MZH^AIS4XJ2ZA11106%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!RGQ#_P"14D_Z[)_.O(J]=^(?_(J2?]=D_G7D5)GC8_\ B_(****1QA11
M10!ZC\,O^0)>?]?/_LHKMZXCX9?\@2\_Z^?_ &45V]4>[A?X,0HHHH.@****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWC_(UW%</HG_ "&;;_>/\C7<5]3D?\"7K^B)D%%%%>T2%%%% !1110 4444
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M% !1110 4444 %%%% !1110 4444 %%%% !113)IHK>)I9I$CC499W; 'XT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH QO%6D_VSX?N+9%S,H\R'_>'
M;\1D?C7B%?1%>/>.-$.DZXTT:8MKLF1,= W\0_/G\:3/-Q]*Z51',4444CS
MHHHH **** .[\'^-OL:QZ;JLA, ^6*<\^7[-[>_;Z=/3%97171@RL,A@<@BO
MGBNB\/>,+_02(L_:+//,+G[O^Z>W\J=SOPV,Y?=J;'LU%9.C>(],UR,&TG'F
MXRT+\./P[_49K6IGJQDI*Z"BBB@84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!RGQ#_P"14D_Z[)_.O(J]=^(?_(J2?]=D_G7D5)GC8_\ B_(****1QA11
M10!ZC\,O^0)>?]?/_LHKMZXCX9?\@2\_Z^?_ &45V]4>[A?X,0HHHH.@****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX]S1HK._M_1O^@O8?^!*?XT?V_HW_07L/_ E/\: YX]S1HK._M_1O^@O8?\
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MZ>_XTF<F+H>TC=;H\;HISH\4C1R*5=2596&"".QIM(\4**** "BBB@ HHHH
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MTR'1]+@L8/NQKRV.6;N3]331VX*CSSYWLB[1113/8"BBB@ HHHH *X3XG_\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+6-#%SNN+4
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M4 %%%% 'O^G_ /(-M?\ KBG\A5FJVG_\@VU_ZXI_(59JCZ2.R"BBB@84444
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MS#YV'.P?W1_4_P"%=+113/:A",(\L0HHHH+"BBB@ HHHH *X3XG_ /(-L/\
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MY5/7Z!3^!>AF%%%%6 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZM5['&45V?\ P@7_ %$__('_ -E1_P (%_U$_P#R!_\ 94!]6J]CC**[/_A
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M_A O^HG_ .0/_LJ ^K5>QQE%=HO@#<P']I]3C_4?_95J1_"Z$?ZW57;_ '8
MO_LQIC6$K/9'F]%>L6_PWT2(YE>ZG]FD 'Z ']:V[/PWHU@0;?38%8=&9=[#
M\6R:+&T<!4>[L>/Z;X>U75B/LEE*Z'_EHPVI^9XKM](^&L,9675KCSF'_+&$
MD+^+=3^&*[ZBBQUT\%3AK+4AM;6WLK=8+6%(8EZ(BX%3444SL2L%%%% !111
M0 4444 %%%% !7"?$_\ Y!MA_P!=F_E7=US7C'1/[;M+:/[1Y/ER%L[-V>/J
M*##$Q<J32/'**[/_ (0+_J)_^0/_ +*C_A O^HG_ .0/_LJD\CZM5['&45V?
M_"!?]1/_ ,@?_94?\(%_U$__ "!_]E0'U:KV.,KUWX>?\BI'_P!=G_G7*_\
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ME^TN/XK@[OTZ?I70I&D2!(T5$7@*HP!3J*9U1A&"M%6"BBB@H**** "BBB@
MHHHH **** "BBB@ HHHH **** .2\4?\A./_ *XC^;5B5UFLZ7]NO$E\[9B,
M+C;GN??WK._X1[_IZ_\ (?\ ]>OD\;@J\\1.48Z-]T6GH8E%;?\ PCW_ $]?
M^0__ *]'_"/?]/7_ )#_ /KUR_V?B?Y?Q7^8[F)16W_PCW_3U_Y#_P#KT?\
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M5>QQE%=G_P (%_U$_P#R!_\ 94?\(%_U$_\ R!_]E0'U:KV.,HKL_P#A O\
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M7L<9179_\(%_U$__ "!_]E1_P@7_ %$__('_ -E0'U:KV.,HKL_^$"_ZB?\
MY _^RH_X0+_J)_\ D#_[*@/JU7L<9179_P#"!?\ 43_\@?\ V5'_  @7_43_
M /('_P!E0'U:KV.,HKL_^$"_ZB?_ ) _^RH_X0+_ *B?_D#_ .RH#ZM5['&4
M5V?_  @7_43_ /('_P!E1_P@7_43_P#('_V5 ?5JO8XRBNS_ .$"_P"HG_Y
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MZ*[/_A O^HG_ .0/_LJ/^$"_ZB?_ ) _^RI'F?5JO8XRBNS_ .$"_P"HG_Y
M_P#LJ/\ A O^HG_Y _\ LJ ^K5>QQE>S5QG_  @7_43_ /('_P!E7H'V#_IK
-_P".TSKPM&<;W1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gl04fjvuohx1000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gl04fjvuohx1000002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ! A$# 2(  A$! Q$!_\0
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M']I'_LO?QA_]6'XBKP2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
GB@ HHHH *_J:_P"#/?\ Y3!V7_9L?QN_]*?!5%% '^J]1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>gl04fjvuohx1000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gl04fjvuohx1000004.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ! A$# 2(  A$! Q$!_\0
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M']I'_LO?QA_]6'XBKP2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
GB@ HHHH *_J:_P"#/?\ Y3!V7_9L?QN_]*?!5%% '^J]1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>gdtodyoqoyfd000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gdtodyoqoyfd000001.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" *(!B$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<[\7?B';_"
M3X5>)/%-TH>W\.Z9<ZDZ9QY@BB9]H]VVX'J2*Z*ODS_@LW\5/^$"_8XN-&C;
M;=>,M3MM,&U]KK$A-S(P]5/DJA]I?>O>X7REYIF^&R_I4G%/_#?WG\HW9X'%
M6<+*LGQ.8O>G"37^*WNKYRLC\D+_ %*XUF_GO+R9KB\O)&GGE;[TLC$LS'W)
M)-0T45_HTDDK(_S4E)R?,]PHHHH)"BBB@ HHHH **** "BBB@ HHHH ****
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M'=/9K9A1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZO-)_P"&'O/_ ,FY#S>BBBO[&/XK"BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YG
M^V3\6F^!G[+7CKQ1',;>[TW294LI1_!=2XAMS_W^DCK\(D3RT51T48K]1?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+CL+S8C(Y^VA_)*RFO1Z1E_Y*^B3/Z;X/^D!@,7RX?/8>QGMSQNZ;]5K*/\
MY,NK:/U"HKB_@C^T/X+_ &C?"_\ ;'@OQ!8ZY:I@3)$Q6>T8YPLL3 /&3@X#
M*,@9&1S7:5^"XK"UL-5E0Q$'"<=&I)II^:>J/Z"PN*HXFE&OAYJ<):IQ:::[
MIK1A1117.= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@/_!3SXK_ /"I
M?V)O&UQ'(B7FN6PT*V5C@R&Z8128_P!H0F9Q_N5[]7YU_P#!>/XK@KX"\"PS
M G=/K][#W&!Y%LWXYNA^%?<>&V3_ -I\2X3#-7BI*<NUH>\T_)VM\SX3Q,SK
M^R^&<9BD[2<'&/>\_=5O-7O\C\ZQQ1117^@!_G<%%%% !1110 4444 %%%%
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M P[ 6F:9AAR,-7Z"45])PKQ5C>'\8\=@.7G<7'WE=6;3?5:Z;]K]SYGBOA/
M\0X)8#,.;DYE+W79W2:7>ZUV[V?0_&O6/^"1GQ[TN7;#X0L]27/WK;6[, _]
M_)$/Z5Q_B/\ X)Z_&[PL&^U?#3Q-)MZ_8XDO?_1+/7[B45^JX?Z0>?1_C4*,
MEY*:?_I;7X'Y-B/HZ\/R7[FO6B_-P:_](3_$_ ;Q%^SY\0/!\7F:OX$\::5'
MUW7FAW4"_FR 5Q\K""5HY/W<BG!5N&'X5_135/6_#FG^)K3[/J5A9ZA!_P \
M[F!9D_)@17OX7Z1=1:8C I^<:EOP<'^9\]BOHUT7KAL>UY2II_BIK\C^>,-F
MBOW:\1_L5_"'Q8CB^^&?@9VD^])'HL$,I_X&BAOUKSCQ-_P2-^ _B&-_*\(W
M6E32'/FV6L7:D?16D9!_WS7TF$^D)DD],3AZL/11DO\ TJ+_  /F,9]'//(:
MX;$TI^O-%_\ I,E^*/QLHK]2/%?_  0G^'=_"QT7Q=XTTN9B2/M36UY$OT41
M1M^;5Y?XQ_X(,>);*$MX?^(FAZG)CA-1TN6Q7_OI'F_/;7U6"\9>$\1H\2X/
MM*$U^*37XGR6.\$^+L/JL,IKO&<'^#:?W(^!Z*^I/&G_  1S^.7A20K9Z/H/
MB11_'IFKQJ#^%QY)_2O)?&?[&_Q8^'[2_P!K?#GQE;QP@F2:+2I;F!!ZF6(,
MG_CU?88'B[),;_NN+IR?93C?[KW_  /C<PX-S[ W^MX.K%=W"5OOM9_)GFM%
M+<(UG<O#,K0S1G:\;C:RGT(/(I*^B\SYIIK1A1110(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "AEW#!Y!HHH ^JOV,_P#@JMXT_9J-GH?B,W/C/P5%LB6WGES?Z9&.
M/]'E8_,H7&(I#MPJJK1C)K]2/@-^T3X/_:6\$1Z]X.UBWU2SX6>+[EQ92?\
M/.:(_-&W!ZC!'*DJ03^!M=1\(/C/XH^ GC>#Q%X1UJ\T/5H1L,L)RL\>03'*
MARLD9(!VN",@'J 1^-\>>#N79WS8O+[4,0];I>Y-_P!Y+9O^:.O5J1^V< >-
M&99&XX/,;U\,M+-^_!?W6]TOY9:=$XG] %%?)_[#?_!5#PS^TXUKX=\4+9^$
M_'4FV.. N18ZNYX_T9V)*N3_ ,L7);D;6DPV/K"OY$SWA_'Y/BG@LQIN$UWV
M:[Q>S7FO3<_L;(>(<OSG"1QN6U54@^VZ?:2W3\GZ[!1117C'M!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH_,,UX<S7+)<N88>=/\ Q1:7R;5G\F9M%%%>N>*%%%% !1110 4444 %%%%
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MO-?S1OUZ=4KJ^]1117P!^A!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!.!7B/Q;_ ."E?[/?
MP)N+JW\6?&OX8:+?6/\ K["7Q':O?1]?^7=',O8]$KLP>7XK&3]GA*4JDNT8
MN3^Y)DRG&*O)V/;J*^#_ !9_P<M?L9^%UD6/XL7&K3PMM,5AX8U9\^X=K98R
M/<-7FNN?\':?[*NDR;;>W^*6J#<!NMO#\*CIG/[VX0^WKGVYK[##>%_%]?6G
MEM?YTY1_]*2.>6-H+>:^\_3JBORYM?\ @[E_9;GN%1M&^+T*L<&1]"M"J_7;
M=D_D#7<^"O\ @Z-_8\\5;?MWC;Q+X:R,G^TO"]])CC/_ "[1S?3_ .MS6E?P
MIXQHQYIY;6^4'+\(W8+'8=_;7WGZ&T5\R?"/_@LY^RK\;X8VT+X\?#J-I2H2
M'5]3719Y"QP L5X(G+'/0#-?2.C:W9^(]*M[[3[NUO[&Z0207%O*LL4RGHRL
MI(8'U!KY',<GQ^7RY,?0G2?:<91?W22-XU(R^%IEJBBBO-+"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JCXD\+Z9XRTB73]8TVQU6PG&)+:\MTGAD'NC @_B*O454)RA)2B
M[-=43.$9Q<9JZ>Z9\Y_%?_@E+\$?BKY\J^%?^$9OIO\ EYT"X:R\O_=AY@'_
M 'ZKYI^+'_!![4K8RS>!?'EI=*6_=V>O6K0LJ^]Q"&#'_MBM?I%17W>3^)W$
MV6V5#%RE%=)^^K=O>NTO1H^"SKPNX7S2[Q&$C&3^U#W'?O[MDWZIGX@_%G_@
MG=\9O@SYDFJ>!=6OK./<?M>D :E"5'5R(2SHOO(JUXJX\N5HV!62,E64C#*1
MU!':OZ**X?XM_LT?#_X[P,OB[PAH.NR,GEBYN+5?M4:^B3KB1/\ @+"OUC)?
MI#5HVAFV%3[RINW_ )+*]_\ P)'Y#GGT<:$KSRC%N+Z1J*Z_\"C9K_P%_P"?
MX'T5^I?QB_X(<> /%9FN/!GB#7/!]P[96WG U.R0>@5RLWXF5OI7RE\9/^"1
M/QF^%*S7%CI-AXRT^,%S-HESOF5<X&8) DA8_P!V,/\ 6OU[(_%;AG-+1IXE
M4Y/[-3W'][]UOR4F?C>?>$7%&57E4PSJ07VJ?OKULO>2]8H^8:*N^)/#6I>#
M-;FTS6-.O](U*W.)K2^MWM[B(_[2. P_$52K]#C.,HJ47=/9GYM4IRA)PFK-
M;I[H****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KVK]BO]MWQ-^QIX[^U:>TFI>&=0E4ZOHSOB.Y'3S8\\),!T;HP
M5LC&/%:*X,TRO"YCA9X+&P4Z<U9I_P!:-;IK5/5:GHY3FV+RS%PQV!FX5(.Z
M:_K5/9IZ-:,_?_X,?&?P[\?_ (=:?XI\+:A'J.DZBF58<20N/O12+U213P5/
M3Z8-=37XA_L/?MJZY^QG\3%O[?S]1\+ZHZIK6DA^)TZ>=$"0%G0?=)P&&5)
M(*_M!\-_B/HGQ=\"Z7XE\.:A;ZKHFL0"XM;F$_*ZG@@@\JRL"K*P#*RLI ((
MK^'O$;P]Q'#.,O&\\/-^Y/\ ]ME_>7W26JZI?W?X:^(V&XHP7O6AB(+WX?\
MMT>\7_Y*]'T;W****_-S],"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+_\ _!>^W_8@TF^^$/PEO[>\^+^I6X74]3C*R1>#H9%R#CD->,I#(AXC5@[
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M"?M>?LU:U^QU^T[XY^%_B!Q-JG@G5Y]-:X6/RUO8U;,-PJY)598C'*H))"R
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M\6=AX4\*:7X$\,:=HFAZ;I^C:+H]M'9V%A8VZ6]K901J$CBBC0!415 554
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MQK\VB<"OV\_X)T?"K_A3_P"Q?X#TV1-MW>Z>-6NLIM?S+MC<;6_VD614_P"
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MIO\ \F5]7_Q!?C;_ *%U3_R7_,Q_M##?SH_6ZBOR1_XC$_V?_P#HG'QC_P#
M33?_ ),H_P"(Q/\ 9_\ ^B<?&/\ \!--_P#DRC_B"_&W_0NJ?^2_YA_:&&_G
M1^MU%?DC_P 1B?[/_P#T3CXQ_P#@)IO_ ,F4?\1B?[/_ /T3CXQ_^ FF_P#R
M91_Q!?C;_H75/_)?\P_M##?SH_6ZBOR1_P"(Q/\ 9_\ ^B<?&/\ \!--_P#D
MRC_B,3_9_P#^B<?&/_P$TW_Y,H_X@OQM_P!"ZI_Y+_F']H8;^='ZW45^2/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P 4W=_^2J+^9_97T=\E^KY)6S&2UK3LO\,%9?\ DSE]P4445^"']!!1110
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M\^?VN_\ @BC+:FXUSX/W)FCY=_#>H7/S+UXMKASSV 28YX)\P\+7]0<%^.6
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M9(W1?[Z^C3QUA\?DG^KU:25?#W<4WK*G)W37?E;<6ELN7N?+YQAG&I[5;/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF6$Q]!8G U8U:;VE"2E%_--HXI0E%VDK,****[B0HHHH **** /T$_X(B_\
M!<?Q-_P3-^(-KX5\57&H>(?@GK5S_P 3#3,F:;0'<G-W9 GY?F.Z2(?+(,D
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M1D@X(++,Y4]"D1]*_.>O3OVSOC(/C[^U)XV\4PSK<6-]J3P6$BGY7M(0(8&
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M2[Q^<;JZ7\7^)G@_BL@<LPRZ]3"]>LJ?^+O'M+Y2L[-_/=%%%?LA^)A1110
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M+*A4Y'\@HHHK[PY0HHHH *=!<26LZ2Q.\<D;!D=#M9".00>Q'K3:* /ZX/\
M@AO_ ,%"&_X*,_\ !/\ \->*=6NEN/''AICX<\5\;6EOH$0BYP H_P!(A>*8
M[0%#R2(/N&OL"OYL/^#3#]KN7X+_ +?^J?#&\N&71?B]I#Q0Q[1M&IV*27,#
MEC]U3;_;4P/O,\8["OZ3Z_S \9^#H<-\55\)0CRT:EJE-=%&=]%Y1DI17DD?
M99?B/;4%)[K1A1117Y4=P5^"/_!XE^UXVM_$3X9? W3KEC:Z';/XPUN-)%:-
M[F;?;6:L!RLD<2W38/5;M#7[VLP12S$*JC))[5_&G_P4O_:G;]M;]O3XI_$Q
M9O/L/$FNS?V6QC\MO[.@ MK(,O9A;0P[O5LGO7]'?1EX768\3RS.JKPPL.9?
MXYWC'\.=KS2]5Y.<5N2CR+[7Y(\,HHHK_08^5"BBB@ HHHH _;#_ (,W?V;C
MJ?Q/^+WQ<NK>98]'TVV\)Z;*5S%*]S)]IN@#_?C6VM.W2<^IK]\*^#/^#:_]
MFYOV=/\ @DKX"ENK62TU7XA3W7C&]5C]\7+A+5Q[-906C?B:^\Z_R[\9N(/[
M7XQQV)B[QC/V<>UJ:Y-/)M.7S/M,OI>SP\5\_O"BBBOR\[ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2]+^#'PL\3>,-<F-OHGA/2KK6=0E _U=O;PM-*WX(C&OXG?BI\2=6^,OQ/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#'Y6C=>H4445^/G[(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7M_P1'_9Q_X9:_X)8_!KPS-&8]2O-"37]0#Q>7*MQJ#->M'(, [HA.(N><1
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M7Z7*ZR*&5E=6&593N5AV((Z@^M?D/7W-_P $]/VC%\=^#%\%ZK<#^V?#\/\
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MO8\/$\%\/XC6M@:,GW=.%_OM<^*==_X(6?"^\21M/\3^/+&1ONA[FUGB3\#
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MIJ_AETW4KC1KQ+BSN)K6XC.4EA<QNI]B.17I7@W]M[XT_#I57P_\7_BCH*H
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M_/[C^DBBOYN_^(PG]IC_ *$?X%_^"75?_EC1_P 1A/[3'_0C_ O_ ,$NJ_\
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M&6?#G_HBOC;_ ,'%K_\ $T?\1EGPY_Z(KXV_\'%K_P#$U_/S11_Q+IP+_P!
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M9WP_\"ZI\4?'NA^&=$MFO-:\1:A!I=A;KUGN)Y%BC0?5V4?C7]L?P6^%>F_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?Z7*Z_[MPEB#[25^IU?S;_\ !W+^THWQ0_X*#>'?AW:WAFT[X6^&XEGMR/\
MCWU&_(N9CU_BM18'IVK]C\!>'_[5XTPJDKQHWJR\N1>Z_P#P-P_X<\_-*O)A
MY>>GW_\  /RGHHHK_3$^/"BBB@ HHHH *_LC_P""6G[-;?LA_P#!._X0?#V:
MU>QU'0_#EO+JENYR8=0N<W5XOX7,\WX5_*S_ ,$M/V;%_:[_ ."B'P@^'TUJ
ME[I^N>)+>75(&.!-I]MFZO%_&V@F_&O[(Z_C3Z6'$&N!R2#_ )JLE_Y)!_\
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M\.3V^F7$0RT%_=8M+-_PN9X2?8&OXX*_ICZ)_#_^_9W-?RTHO_R>:_\ 3?\
M5CQ\\J_#3^?^7ZA1117]E'SX4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 $XK^S'_@FO\ LUC]D']@GX3?#EK-;&^\-^&[5-4A4[E&HRKY
M]Z0<#AKJ69OQK^5G_@DC^SC_ ,-8_P#!2CX-^!Y+>&ZL-0\207VI03?ZN>QL
M]U[=1G_>@MY5'NPK^Q6OXQ^EAG]YX')(/92JR7K[D'^$SZ#(Z7Q5/E_G^@5\
MW_\ !7W]HG_AE;_@F9\:/&D<UQ;7UKX:GT[3YH#B2"]O2ME;2#_<GN(V/LIK
MZ0K\??\ @\/_ &AO^$-_9'^&?PTMYI([KQUXCEU>Y"-\LEII\.TQN/1IKR!Q
M[P^QK^<O#/(?[9XIP.7-7C*I%R7]V'OR_P#)8L]?&5?9T)3\C^>&BBBO]6SX
M@**** "BBB@ HHHH **** "BBB@ HHHH **** "O4OV,OV/O&W[=_P"T9X=^
M&7@&P6\UWQ!-AYYB5M=,MEYFN[AP#LAB7+$@%F.%16=D1O._"_AC4O&_B73M
M%T73[[5M8UBZBLK"QLH&GN;V>1PD<44:@L\CLP554$DD  DU_55_P0M_X)":
M7_P2_P#V<UO-=M;:[^,'C:".?Q/J =9?[.3[T>F0,I*B*(G+LI/FRY8LR+$J
M?E'BYXF8?@_*75C:6)JW5*+[]9R7\L>O=VCI>Z[L#@WB*ENBW/H3]@G]A[P7
M_P $\OV8] ^&7@BUC6RTM//U#4&A"7.N7SA1->SD9+2.54 $G8B1QKA(U ]D
MHHK_ #,QV.Q&-Q$\7BYN=2;<I2>[;=VV?81BHKECL%4/%/BG2_ WAG4=:UO4
MK#1]&T>VDO;^_OKA+>ULH(U+R2RR.0J1HH+,S$  $D@"H_&GC32/AQX0U3Q!
MX@U*QT70]%M9+[4+^]F6&WLX(U+R2R.Q 554$DDX %?S'_\ !<W_ (+P>(/^
M"CWBR]^'_@.YO=!^!^DW?[N$;X;CQ=)&P*7-VIP1"&4/% 0-IVNX,@01??\
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MK^06O[2^BAD%J..SN:^)QI1?HN>?WWA]Q\[GE76-/Y_U^(4445_81X(4444
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M (3']J_XF?$ZZACDMO _AZ'1K3S$.5NM0F+>8AZ96&SF0^UP/45_0U7YO_\
M!K%^SG_PI+_@E5I/B*X0KJ'Q0UR^\1R!X]LD4*,+*!,X!*E;0RKU_P"/@GO7
MZ05_F+XX9_\ VMQGC:D7>-.2I1_[AKE?WSYG\S[++:7L\/%=]?O"O&OVE_\
M@GM\%OVQ_$FFZO\ %#X=Z!XTU+2+8V=E/J*NYMHBQ<JH# #+'/3->RT5^88+
M'XG!U57PE25.:VE%N+UWU33U.R45)6DKGRC_ ,.,_P!D?_H@W@7_ +\2?_%T
M?\.,_P!D?_H@W@7_ +\2?_%U]745[?\ KIQ#_P!!U;_P;/\ ^2,_J]+^5?<C
MY1_X<9_LC_\ 1!O O_?B3_XNC_AQG^R/_P!$&\"_]^)/_BZ^KJ*/]=.(?^@Z
MM_X-G_\ )!]7I?RK[D?*/_#C/]D?_H@W@7_OQ)_\71_PXS_9'_Z(-X%_[\2?
M_%U]744?ZZ<0_P#0=6_\&S_^2#ZO2_E7W(^4?^'&?[(__1!O O\ WXD_^+H_
MX<9_LC_]$&\"_P#?B3_XNOJZORY_X../^"T*_L._"J3X1?#?6)H?C!XTLR;J
M^LI-DGA'3I,J9_,!REW,,K"%^:-0TI*$0^9]%PGBN+^(LTI93EV,K.<WO[6I
M:*ZRD^;2*6K^25VTC&O'#TH.<XJWHC\N?^#@7XD?LZ>$OC@WP;_9\^%W@SP[
M'X)O#_PE'BG3XRT]]?J&0V$!+$+#"2?-;J\HV@*L),OYUT45_I=PQD,<FRRE
MET:DJK@M9SDY2E+K)MMO5[*]DK):(^0K5?:3<[6] HHHKWC(**** "BBOT__
M .#<W_@B_)^W7\6X_BQ\1-+AD^#O@B]'DV5Y%O3Q=J*886X0C:UK$=K3%OE<
ME(@KAI3'\YQ9Q3@.'<KJYMF,K0@MNLGTC%=7)Z+[W9)LVH4959J$-S["_P"#
M8?\ X(Q+\+?#6F?M+?$NP;_A)==M2_@;29XL?V792H0=2DSR9IT8B(# 2%B^
M6,R^5^S]%%?Y=<;<98_B?-JF;8]ZRTC'I"*^&*\EU?5MMZMGV>'P\:--4XA1
M17Y)_P#!T#_P5M?]F+X/?\*%\!:G''X]^(5B7\174.XR:'HTF4,:L,*L]UAD
M_B*0K(=JF2%QEP=PGC>),WHY1@5[U1ZOI&*^*3\DOO=DM6AXBO&C3=21\._\
M'&O_  6TF_;1^(MY\&/AAKBO\'O"]V!JE]82YB\97\39W^8IQ)90N/W0&4D=
M?.^<+ R?E;117^I'"/"F X<RNGE.71M""U?64NLI/K)_@K)622/B\17E6FYS
M"BBBOI3$***]4_8J_8_\8?MW_M+^%_A?X)M5FUGQ)<[)+B3BWTRV7YI[N8\8
MCBC#,0/F8@(H9V53RXW&4,)AYXK%24*<$Y2D]$DE=M^2148N3Y8[GHO_  2\
M_P""67Q"_P""IOQT'A?PBJZ/X=TDQS>)/$]U TEGH5NQ./E!'G7#@,(H RER
MI)9$5Y$_J)_8%_X)F_"'_@FU\./[!^&?AN.UO;I%&J:_?;;C6-98 <SW&T';
MD9$2!(E)8JBEF)Z3]B#]BOP+_P $_P#]G'0OAG\/]-6STG24\RZNG -WK-XP
M437MR_\ '-(5&?X454C0+&B(OK5?YP^+7C%C^+,7+#863IX*+]V&SG;[52V[
M>ZCM'I=W;^MP.7QH1YI:R_+T"BBBOQ,]$*_-#_@OW_P0[T/]O3X5:Q\3OAWH
M]KI_QP\.VGVEOLT17_A,[>%,&TF"CYKH1J%@E())1(6(0JT7Z7T5]!POQ1F'
M#^94\TRV;C4@_E)=8R76+ZKYJS29E6HPJP<)['\+]%?</_!Q)^R+;?LA?\%3
M_'5GI=JMGX?\>I%XTTN(.&V+>,_VD   (HO8KL*@X5 @'%?#U?ZM\.YU1SC*
M\/FF'^"M",TNW,KV?FGH_-'Q%:FZ<W!] HHHKV3,*_07_@VW_P""@$G[%'_!
M0W1] U6\:'P/\8&A\,:NC$^7!=LY_L^Z(R!E)W,19CM2*ZF8]!7Y]4Z*9[>5
M9(V:.1"&5E.&4CH0:\+B?A_#9YE5?*<6O<K1<7Y/I)><7:2\TC2C5=.:G'H?
MW/45X5_P3*_:G;]M;]@7X5_$ZXF6XU+Q-H47]JR)%Y2-J,!:VO=J]E^U0S8'
MIBO=:_R4S+ 5L#BZN"Q"M.G*4)+LXMI_BC[J$E**DMF%%%%<91P?[4GQQM?V
M9OV:_'_Q$ODCFMO _AZ^UQH7<+]H-O \JQ DCYG90@&>2P Y-?Q2ZUK5WXDU
MF\U&_N)+N^OYGN;F>0[GFD=BSNQ[DL22?>OZ:/\ @ZQ_:,'P;_X)<77A6WE5
M=0^*7B"RT3:)"LJ6T+&^FD7!Y7-M%$W;%QCO7\QM?WA]%?(/J^18G-IK6O4Y
M5_AIK?\ \"E)?(^9SJK>JH=E^84445_4AXH4444 %%%% 'Z4_M+_ +<TW[$O
M_!'CX5_LK>!;QK'Q?\2-%'C7XDZG8RB-H[+5?]+L]-)4EA+-8R6GGCY1Y*QH
M=ZSR*GYK5H>*_%6H^.?$M]K&K7<U]J>ISO<W5Q*?FED8Y)/;\!P.@P*^L/\
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M^_\ %&MW'B2]V2X9(;*'R(D=<\K))>,PR,;K;U%?S]U^A/\ P<\?M'#X^?\
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MDK(*SO%_BS3_  %X3U37-7NH['2=%M);^]N9#A+>")"\CM[*JDGZ5HU\/_\
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M%%%?YUGU@4444 %%%% !1110!%?7T.EV4UU=316]O;HTLLLKA$B11EF9CP
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ME'DQ/L9/L]N@)P2)I!TSG]E_^(A?]C?_ *+AHO\ X*-2_P#D:OY+:*_#>-O
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MHTZK\6?A!\);6>58]$TNZ\5:C$K9CF>ZE^S6V1CAXUM;GOTGZ<BOWTK^0_\
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MV_V5+Y/L#7]!C_\ !GC^SD7.WX@?&P+G@'4]+) _\ *_-_\ X-:?V<Q\</\
M@JQHNO7$8?3_ (8Z)?>)) \6Z.29E6S@3.,!P]WYJ]#FW)[5_4)7\;_2&\4,
MYRG/*.5Y)B94E"GS3Y;:RFW9.ZZ12:_Q'T&4X.G4I.=17U/R9_X@\/V<_P#H
MH'QL_P#!EIG_ ,@4?\0>'[.?_10/C9_X,M,_^0*_6:BOP#_B,O&W_0QJ?>O\
MCU/[/P_\B/R9_P"(/#]G/_HH'QL_\&6F?_(%'_$'A^SG_P!% ^-G_@RTS_Y
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MA_P35_9:UKXE>+%^W26_^AZ+H\<PAGUW4'5C#:HQ!V [69WVMLC1VVL0%/\
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M  4/_;SR\XGRX=KNTOU_0_.6BBBO]&#Y,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _>;_@S(^&=Q9>!?CUXRFA7[+J5_H^C6LNWD/;QW
M<TZ@_2ZMS^ K]NJ_/'_@UW^!1^#7_!)#PMJ4D<T-W\1-:U+Q//'(""N9191$
M>S064+C'4/FOT.K_ "X\9,V68\:9AB([*IR?^"TJ?_MI]IE\.3#P7E?[]0K^
M8_\ X.M?VC#\8O\ @J)-X3MYI&T_X6^'K+1B@DW1-=3J;Z:1?1BMS!&WO!CM
M7]-&L:Q:^'](NM0OKB*ULK&%[BXGE;;'#&@+,S'L  23Z"OXI?VJOCI=?M._
MM,_$#XC7D<D,WCCQ#?:YY#N7-LMQ.\J1 DGA%94'/ 4"OU7Z+&0?6<^Q.:S6
ME"GRK_%4=D__  &,E\SASJK:DH=W^1P-%%%?WD?,A1110 4444 ?=O\ P;G?
ML6I^V/\ \%.O"+:G:&Y\+_#53XRU8'(21K9T%I$3@JVZ[> LA^_''*.QK^K.
MORC_ .#2#]DU?A%^P7X@^*%Y;[-6^+FMM]FE$NX-IFGM);0C;_ WVIK\G^\O
MEGL*_5RO\V_I!<5/..+JU"#O3PW[J/JM9OUYVX^D4?7951]G03>\M?\ (***
M*_#ST@HHHH **** "BBB@ HHHH **** "BBB@#\(_P#@\I_9XDA\0?!GXL6M
MG(T=Q;WGA+4[K'RQE&%U9QD^K>9?G_@!K\.Z_KF_X+F?L6R_MT_\$U/B!X5T
MVQ6^\5:' OB;PX@A,LS7UGND\J)1R99X#/;K[W%?R,U_HC]&SB2&8\)1P$G^
M\PLI0:Z\LFYP?IJXK_"?)YO1<*_-TD%%%%?T&>6%%%% !1110 4444 %%%%
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M7/Z^#_P3F_9[/_-"/@S_ .$5IO\ \9H_X=S?L]_]$'^#/_A%:;_\9KV:BO\
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M7HE%%?Y$XK%5,16GB*SO*;<F^[;NW]Y]W&*2L@HHHKG&%%%% !1110 4444
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MSQ5_P3(_:.\$K,^J? 3XR6<-N<23MX.U!H%_[:"(I^1K^R^BOT3!_2LS^/\
MO6#HR_P\\?SE,Y99'2^S)_@?PZ^+/ 6N^ KPV^NZ+JVBW"G:8K^SDMG!],.
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MQ.65%K2J2A\HR:3^:LUW1]Y1J<]-3[H****\,T"BBB@ HHHH **** "BBB@
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M\!;?]EO]EGX=_#BV:&9/!'AVQT5YHEVK<RP0(DDV,#F1PSGCDL:_EWZ4^?\
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MIYC'_;*RU3_Y=P>J@O[SWGYVC]F[^3S+'>VGR0^%?CY_Y!1117] 'EA1110
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M;2;>::#4OB5JMCX6MGB<!D1G-U<9'=&M[66(_P#78>HK]#J_GW_X/&_VB_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?R[_P#!TC^T:/CG_P %6M=T.WE633?ACHUCX9B:.0M'),5:\G;&<!UDNVB;
MO^X [5_3MXR\7:=\/_"&JZ]K%U'8Z3HEG-?WMQ)]VW@B0R2.?954G\*_B?\
MC_\ &'4/VAOCMXT\?:LBQZIXVUV]UZ[C0Y6.6ZG>9E7_ &07(' X K^J/HK9
M!]8SK%9O-:48**_Q5'NO2,6O^WO0\7.ZMJ<:?=_D<C1117]V'S(4444 %%%%
M 'U]_P $&OV<S^TU_P %7_@_H\L,DFFZ#J__  E%^PCWI''IR-=H'!_@>:*&
M(_\ 745_7%7X-?\ !FS^S>UYXV^,7Q>NK>=5T^RM?"&F3_\ +*8S.+N\7_>0
M06)^DIK]Y:_SO^DMQ!]?XN>"@_=PT(P_[>E[\G]THI_X>Y]7D]+EH<W=_P#
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M[&#3;"V3[MO;PQK'&@]E50/PK5HHK_)&<Y3DYS=V]6^[/NMM HHHJ0"BBB@
MK\6?^#R#]HS^Q?@K\(OA1:S1F3Q#J]SXGU!$DQ)%':1?9X P[I(UW,1G^*W]
MA7[35_*__P '-'[2'_#0?_!6?QE96]Q#<Z7\.+"S\(V;Q'@F%#/<JW'WDN[F
MYC/7_5CZ#]V^CGD']H\94J\E>.'C*H_6W+'Y\TDUZ'F9M5Y,.UWT/S_HHHK_
M $>/D@HHHH **** /K;_ ((6_LZ']IS_ (*L_!O0I(V?3](UM?$M^WE^9&L.
MG*UX%D&"-DDD,<1SQ^] [U_757X'_P#!FY^SDVI_%'XP?%JZMYECT?3+7PGI
MLI'[J9[F3[5= ?[<8MK3\)_<U^^%?YX_28S_ .O<6_4H/W<-",?^WI>_)_=*
M*?H?59/3Y:'-W?\ P HHHK^>3U@K^?G_ (.=O^"SO_"W?$^H_LV?#/4,^%]!
MN@OC?5K>7(U>]B?(TZ/''DP.H,I))>90N%$),OV)_P '&W_!:!?V%_A/)\)?
MASJTT7Q@\;61,][9R;9/"6G/E3<;P<K=2_,L(7YD >4E"(O,_FAK^P/HZ^$O
MMIPXLS>'NQ=Z$6MVO^7K79?8ON_>Z1;\'-L=;]Q3^?\ E_F%%%%?VH?.A111
M0 4444 %?N%_P;6?LN? O]EG1(?CU\7/BU\']/\ B+K=LT?A?1+[Q9IRW'AF
MRE3:]S,K2YCNYT8J$QNBA8ACNE>./\/:*^-XZX5K<195/*:>)E0A4TFXI-RC
MUCJU9/KU:TV;OT8:LJ4^=J]C^SS_ (>*?L^_]%U^#?\ X6FF_P#QZC_AXI^S
M[_T77X-_^%IIO_QZOXPZ*_GW_B4[+?\ H85/_ (_YGJ?VY/^5']GG_#Q3]GW
M_HNOP;_\+33?_CU'_#Q3]GW_ *+K\&__  M--_\ CU?QAT4?\2G9;_T,*G_@
M$?\ ,/[<G_*C^SS_ (>*?L^_]%U^#?\ X6FF_P#QZC_AXI^S[_T77X-_^%II
MO_QZOXPZ*/\ B4[+?^AA4_\  (_YA_;D_P"5']GG_#Q3]GW_ *+K\&__  M-
M-_\ CU'_  \4_9]_Z+K\&_\ PM--_P#CU?QAT4?\2G9;_P!#"I_X!'_,/[<G
M_*C^SS_AXI^S[_T77X-_^%IIO_QZNN^$W[2WPY^/EW?6_@7X@>"?&EQI:))>
M1Z#KEKJ3VBN6"-((78H&*L 6QG:<=#7\2M?T:?\ !H)^SH?A[^PWXX^(UU;2
MP7GQ(\3?9K>1ONW%CI\?EQN/I<3WJG_<K\[\4/ C+.$LAGFT<9.<^:,8Q<8I
M-R>NJ=](J3^1UX/,YUZOL^4_6RBBBOYC/9/RO_X.B?\ @E_)^UG^S-;_ !D\
M(Z>+CQ]\);21M0BB4>=JVA9,DR=,L]LQ>=!N "/= !G=!7\U]?W05_,[_P '
M$7_!$^\_85^*EY\6OASI*R?!?Q=>;Y[6SBVKX-OI&YMV11A;21CF%QA4),+!
M2(C+_9?T;?%&G&"X2S.=G=NA)O>^KIW[WNX=[N/\J?S^;X)W]O#Y_P"9^8-%
M%%?V2?/A1110 5T'PK^*OB3X'_$32?%O@_7-2\-^)=!N!<V&I6$QAN+60 C*
ML.Q!*D'AE8@@@D'GZ*SJTH58.G42E&2:::NFGNFNJ8)M:H_?K_@FK_P=H>&/
M%>BZ?X7_ &EM/D\-:W;Q+"/&6CV3SZ=?E5.7NK2,-+!(V%R8%DC9G8[($ %?
MKO\ !;]H'P+^T=X277OA_P",?#/C31F(4WFBZE#?11L1G8QC8[7'=6PP(((!
M%?Q'5J>#/'.M_#CQ%;ZQX=UC5-!U:U.8+W3KN2UN(3_LR1D,OX&OYIXQ^C'D
M>9598G)JKPLGJXVYZ=_)74HW\I-+I%;'L8?.*D%RU%S?F?W&45_'_P##W_@M
M3^UA\,8]NF_'SXD7 R3_ ,3;5#J__I6):[+4O^#A[]LK5K%;>7XWZLL:+M!A
MT72X9,8QRZ6P8GW)S7Y-6^BGQ&IVI8J@X]VZB?W*#_,[EG='K%_A_F?UG5YW
M\>OVNOA;^RUI@NOB/\1/!O@F.2-I(DUG5X+2:Y !)$4;L'E;@_*BL3C@5_(Y
M\1_^"I/[2/Q:CN(]?^.WQ6O+6Z79-:IXFN[>UE'H88W6,_\ ?->$W-S)>W,D
MTTCS33,7D=V+,['DDD\DD]Z^CRCZ)U9R4LTS!)=53@VW_P!O2:M_X"S*IGB^
MQ'[V?T;_ +8?_!W!\$?A+;76G_"/P]X@^+&LJH$5]/&^BZ,I(/)>9/M+E3@E
M1 JL.!(.H_&O]OK_ (+*_'S_ (*.2S6?CSQ<UCX2D<.GA705:PT9<%67?%N9
M[@AD#*;AY2C9VE1Q7RS17[_P;X.<+<-25?!4.>LMJE1\\UYK11B_.,8L\K$9
MA6K:2>G9!7Z4?\&M_P"VN/V8?^"C%OX)U6^^R^%_C-:#0)5DD"0KJ<9:73Y&
MXRS,YFMD _BO?:OS7K1\(^+=2\ ^+-+U[1;VXTW6-%NXK^PO(&VRVL\3B2.1
M#V964,#ZBOK^+N':.?9-B<HK[5H.-^SWC+_MV24EZ&-"LZ515%T/[CZ*\E_8
M1_:HT_\ ;;_8]^'GQ4TU;>*/QEH\5Y=00,6CL[Q<Q7=N"W)$5PDT>3U\O->M
M5_DOCL'6PF(J83$1Y9TY.,EVE%V:^31]Q&2DE);,*_C]_P""SG[1?_#4_P#P
M5"^,_BV&:.?3QXAET;3Y(G+Q2VM@JV,,B?[,B6XDX[R$]Z_JD_;[_:.7]D7]
MBGXH_$I9K>&\\(>&[R^T_P \9CDOO**VD9X/W[AHDZ?Q5_%\S%V+,2S,<DGJ
M:_KCZ*&07K8[.YK91I1?J^>?W6A]YX6>5=(T_G_E^HE%%%?VD?/!1110 444
M4 ?T&?\ !G/^SG_PC'[-_P 5?BI=1XG\7Z[;^'[(2189;>QA,KR(V/NR27FT
MX.-UM[5^RE?,_P#P1Q_9R_X93_X)B_!GP=-!-;:A'X=AU;4HIE"RPWE\6O;B
M-L=XY;AX_H@KZ8K_ "G\3\__ +:XJQV8)WC*HU%_W8>Y'[XQ3/ML'2]G0C#R
M"BBBO@SJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#\@_P#@M3_P;0:3^TS?:I\4OV?;33?#?Q F1[C5O"FY+72_$LO+&6W8D):W
M3]&!(AE.UF\IO,DD_GO\;^!]:^&?B[4?#_B+2=2T'7='G:UOM.U"V>VNK.53
MAHY(W 9&'<$ U_<97Q]_P5._X(L_"C_@J9X46?7H?^$3^(FG0-#I7C#3;96N
MXEQ\L-S'E1=P!L$([!D^;RWCWON_J#PF^D)B<G4,IXC;JX964:F\Z:[/K."_
M\"BMN96BO%QV5*I[]'1]NC_R/Y(**]^_X* _\$SOBW_P35^)J^'?B5X?:"SO
MBQTG7K'=<:/K2*2"8)]H^<8RT3A)5!4L@#*6\!K^YLMS/"9AAH8S U%4IS5U
M*+337JOQ[/1GS<X2@^62LPHHHKN)"BBB@ HHHH **** "BBB@ HHHH ****
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MMK]2/4&)VKXC'\/YK@;_ %W#5*=M^>$HV^](Z(UH2^%I_,["BBBO'- HHHH
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M44 %%%% !115SP_X>U#Q;KEII>E6-YJ>I:A*L%K:6D+33W,C'"HB*"S,3P
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M_#'5/!GCSPWI/BOPOK47E7>G:C )8I.ZL.Z2*<,DB$.C ,I5@"/P)_X*N_\
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MP!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>SI.RBK)7<&WIU;;>[=SAJ9;AYR<Y1U?F_\ ,_!O_B#!UO\ Z.$TO_PC)/\
MY-H_X@P=;_Z.$TO_ ,(R3_Y-K]Y**[O^)A.//^@U?^"J7_R!/]E87^7\7_F?
M@W_Q!@ZW_P!'":7_ .$9)_\ )M'_ !!@ZW_T<)I?_A&2?_)M?O)11_Q,)QY_
MT&K_ ,%4O_D _LK"_P OXO\ S/P;_P"(,'6_^CA-+_\ ",D_^3:]L_X)T?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!^MW_!H'^S>OQ$_;?\ ''Q)
MNK>&>S^&WAL6EL[??M[_ %&0QQNO_;M;WJ'_ *Z"OZ,J_,K_ (-1/V<A\'_^
M"82^+[B"-=0^*7B&\U=9-A646ENPLH8V]@]O<2+[3YZ$5^FM?YD^.O$']J\:
M8R<7>-)JE'R]FK2_\GYG\S['+:7)AX^>OW_\ ****_(3O"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\+$8.M1^-:=^AX_1117Z <H4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ0EM*+4D_1JZ9YLHN+M):A111742%%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJGAGXP:/'C9':RC1]6(QEF:VN'\G Z )<N[=E[5^</QG^ /CG]G+Q:V@^/\
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M967RYEX/S1LP..M>=U^R87%T,335;#S4XO9Q::?HUH>?*+3LPHHHKH$%%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C_B]^SQX
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M-RKZ66(C:.99?&7=TYN/_DLHRO\ ^!(XZF1K[$_O1_$?17]:WQ:_X-]_V/\
MXR7LMUJ'P4T'2KJ0$*^@WEYHT<9/<0VLL<.1VRA'M7S+\3_^#/[]GOQ,MS-X
M7\;_ !4\+74QS%'+>6>H6<'L$:W64_C-7Z-EGTH.$L198J%6B^MX*2^3A)M_
M^ KT..>35UM9G\X=%?M;\3_^#,SQ=IMHTG@OXZ>'-:G.2L.M>')M,1?0&2*:
MX)]SL'TKYZ^*7_!J1^UI\/XBVDZ?\/\ QRV,[=#\1K"Q]O\ 3H[8?K7WV7^-
M'!.-M[',::O_ #\U/_TM1.667XF.\'^?Y'YKT5]6?%#_ ((=_M;?"%F&K? 7
MQY=[3@_V);)KGY?8GFS^%>%?$S]F;XD?!8N/&7P^\<>$C'][^VM"NK#;]?-1
M:^VP'$>4XZWU+%4ZE]N6<97^YLYY4IQ^)-?(XBBC.:*]HS"BBB@ KVK_ ()Q
M?LV-^U]^W=\*/APUK)>6/B?Q):Q:G$APW]GQOYUZP/JMK',W_ :\5K]9?^#0
MS]FQ?B5^W?XP^(]W:QSV/PQ\-F*VE)^:VU#4',,3#ZVT5^I_WA7QGB)Q!_8G
M#6-S-.TH4Y<K_OR]V'_DS1T86G[2M&'F?T=T445_D\?<!1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?Q1G& >69EC)5*,FFXM1U:=UJHIZ/7<*>#HTY<\(V84445\&=04444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI^XFO)\O-\S[3 4O9T(Q\K_?J%%%%?FYV!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YO_P#!TY^T
M?_PI#_@E;JWAVVDV:E\4-;LO#D>R7;+' K&]G<#()0I:B%NHQ< 'K7\O]?L!
M_P 'A?[1X\;_ +7/PW^&-K-#):^ O#TNK7?EN=R7FH2@&-QTRL%I;N/:X/J:
M_'^O])/H\\/_ -F<&4*DE:6(E*J_1OEC]\(Q?S/D<UJ\^(:[:!1117[@>:%%
M%% !7>?LL_ RZ_:<_:6\ ?#JRDDAN/''B&QT,3(A<VRW$Z1-*0 ?E16+D]@I
M-<'7Z9?\&I/[./\ PN/_ (*@P^+;B&1M/^%OA^\UD.8PT37<ZBRAC;/1MEQ/
M(I];?/45\OQMGRR7(,7FE]:5.37^*UHKYR:1MAZ?M*L8=V?TR:'HEGX9T2ST
MW3[>*SL-/@2VMH(EVI#$BA411V 4  >U6J**_P E)2;=WN?=!1112 **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHKP/\ X*D_M*M^R%_P3Q^+WQ"@NFL=2T+PY<1Z7<*,F'4+C%K9M^%S
M-#^%=V6X"KCL92P5#6=2481]9-)?BR9R48N3Z'\K?_!53]I-?VN_^"BWQ@^(
M$%U%?:=K7B.>#2[B,86?3[7%I9O^-M!"3[DU\_T45_KQE>7TL!@J.!H*T*48
MPCZ122_!'P<Y.4G)]0HHHKN)"BBB@ K^C#_@T"_9N/P\_8D\=?$JZMYH;WXD
M>(Q9VS-]R>PTZ,I&Z_\ ;S<7J'_KF*_G/K^R[_@F?^S5_P ,?_L!_"7X<R6:
MV&H>'/#EL-4@#;@FHS+]HO2#[W4LQ_&OYI^E%Q!]4X9I99!^]B*BNN\*?O/_
M ,FY#V,EI<U9S[+\_P"F>Y4445_ )]0%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR_B_\P_X@MO^KE/_ #'O_P!\Z/\ B"V_ZN4_\Q[_ /?.BBC_ (F X^_Z#_\
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F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>gl04fjvuohx1000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gl04fjvuohx1000003.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ! A$# 2(  A$! Q$!_\0
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M']I'_LO?QA_]6'XBKP2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
GB@ HHHH *_J:_P"#/?\ Y3!V7_9L?QN_]*?!5%% '^J]1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gl04fjvuohx1000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gl04fjvuohx1000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ! A$# 2(  A$! Q$!_\0
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M']I'_LO?QA_]6'XBKP2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
GB@ HHHH *_J:_P"#/?\ Y3!V7_9L?QN_]*?!5%% '^J]1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
